Global Drug Delivery Devices Market 2022-2028

December 2022 | 77 pages | ID: GD762A38C610EN
Gen Consulting Company

Abstracts

According to market research study published by Gen Consulting Company, the market size of the global drug delivery devices sector is expected to rise by USD 140.0 billion with a CAGR of 7.4% by the end of 2028.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global drug delivery devices market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the drug delivery devices industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the route of administration, application, end user, and region. The global market for drug delivery devices can be segmented by route of administration: injectable, topical, ocular, others. The injectable segment captured the largest share of the market in 2021. Drug delivery devices market is further segmented by application: cancer, cardiovascular, diabetes, infectious disease, others. The diabetes segment held the largest share of the global drug delivery devices market in 2021 and is anticipated to hold its share during the forecast period. Based on end user, the drug delivery devices market is segmented into: hospital, ambulatory surgical center, others. In 2021, the ambulatory surgical center segment made up the largest share of revenue generated by the drug delivery devices market. On the basis of region, the drug delivery devices market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Among these, North America was accounted for the highest revenue generator in 2021.

Market Segmentation

By route of administration: injectable, topical, ocular, others

By application: cancer, cardiovascular, diabetes, infectious disease, others

By end user: hospital, ambulatory surgical center, others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The global drug delivery devices market report offers detailed information on several market vendors, including Antares Pharma Inc., Bayer AG, Becton, Dickinson and Company, BIOCORP, GlaxoSmithKline plc, Johnson and Johnson, Merck Group, Molex LLC, Novartis AG, Pfizer Inc., Roche Holding AG, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services Inc, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global drug delivery devices market.
• To classify and forecast the global drug delivery devices market based on route of administration, application, end user, region.
• To identify drivers and challenges for the global drug delivery devices market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global drug delivery devices market.
• To identify and analyze the profile of leading players operating in the global drug delivery devices market.

Why Choose This Report

• Gain a reliable outlook of the global drug delivery devices market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION

Injectable
Topical
Ocular
Others

PART 6. MARKET BREAKDOWN BY APPLICATION

Cancer
Cardiovascular
Diabetes
Infectious disease
Others

PART 7. MARKET BREAKDOWN BY END USER

Hospital
Ambulatory surgical center
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

Antares Pharma Inc.
Bayer AG
Becton, Dickinson and Company
BIOCORP
GlaxoSmithKline plc
Johnson and Johnson
Merck Group
Molex LLC
Novartis AG
Pfizer Inc.
Roche Holding AG
Teva Pharmaceutical Industries Ltd.
West Pharmaceutical Services Inc
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER